News - UF Innovate

UF/IFAS Researchers Explain Science Behind Genetically Modified Mosquitoes

South Florida residents seeking science-based information about genetically modified mosquitoes can access a new, online resource from University of Florida scientists at the UF/IFAS Florida Medical Entomology Laboratory.

Can Handheld DNA Testing Technology Stand Up to Seafood Fraud?

When LeeAnn Applewhite started running DNA analysis on commercial seafood samples in 2015, 75 percent of them – species ranging from grouper and snapper to catfish and shrimp – were mislabeled. “We were testing thousands of samples, and some of it was unintentional mislabeling; it was a bycatch species with [species like] grouper or snapper but the whole load was not erroneously labeled,” said Applewhite, co-founder and president of UF Innovate | Sid Martin Biotech graduate Applied Food Technologies.

Artificial Intelligence Can Combat Deepfakes, Cybercrimes and Snooping

University of Florida researcher Damon Woodard is using artificial intelligence methods to develop algorithms that can detect deepfakes — images, text, video and audio that purports to be real but isn’t. These algorithms, Woodard says, are better at detecting deepfakes than humans.

FDA Includes UF Researcher As Advisory Board Considers Gene Therapy Risks

FDA's Cellular, Tissue, and Gene Therapies Advisory Committee experts prepare for a two-day meeting to talk about high-dose that gene therapy developers and investigators are allowed to give patients in each trial.

Axogen RECON(SM) Clinical Study Completes Subject Follow-Up

UF startup and UF Innovate | Sid Martin Biotech graduate Axogen, a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, announced that the RECON Clinical Study supporting its Biologics License Application (BLA) for Avance Nerve Graft has completed follow-up of study subjects.

UF Health Neurosurgeon Awarded $38 Million Grant To Lead National Stroke Prevention Trial

The National Institutes of Health awarded a $38 million, five-year grant to Brian Hoh, M.D., M.B.A., the University of Florida’s chair of neurosurgery, to test two new prospective treatments for symptomatic intracranial arterial stenosis, a leading cause of ischemic stroke worldwide.

Vital Signs: Leveraging Data for Better Health Outcomes

UF's Azra Bihorac says one of the most important collaborations for doctors and nurses in the future will be with the computer at a patient’s bedside.

Computing Power and Data Drive Artificial Intelligence Advances

Although data has been called the new oil, a precious resource, finding the relevant in the midst of the irrelevant is a task too big for mere mortals. It takes supercomputing, says University of Florida research computing director Erik Deumens, to turn data into knowledge.

Oragenics’ SARS-CoV-2 Spike Protein Produces Neutralizing Antibodies in Mice With Intramuscular and Intranasal Adjuvants

UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announces that the stabilized pre-fusion spike protein trimer produced by its Canadian collaborator and licensed by the company from the National Institutes of Health (NIH) generates neutralizing antibodies in mice after immunization against SARS-CoV-2, when administered with several novel intramuscular (IM) and intranasal (IN) adjuvants.

CFO of Life Science Startup Axogen Shares How Firm Navigated Pandemic’s Health Care Disruptions

UF startup and UF Innovate | Sid Martin Biotech graduate Axogen, a life science company that is developing products for nerve repair, is ramping up hiring for scientists and engineers after navigating through the negative disruptions from the Covid-19 pandemic.

UF News